About Pear Therapeutics. Name of Issuer; Pear Therapeutics, Inc. Street Address 1 Street Address 2; 55 Temple Place: 3rd Floor: City State/Province/Country ZIP/PostalCode Phone Number of Issuer Number of Pending Tests*: 995. Pear Therapeutics specialises in biotech. We are building a product pipeline that will focus on novel medicines that will enable targeted delivery of oligonucleotides - and potentially other drug payloads - to a number of different cell types. please review it carefully. MT143186 Email Article All set! Source: Kern County Public Health Services Department ... Phone… Aprea Therapeutics Inc., (NASDAQ: APRE) is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics to reactivate the mutant tumor suppressor protein p53, the most commonly mutated gene in cancer. Pear Therapeutics is a private. The Pear Connect Patient Service Center will reach out to you or your office staff via phone once a … NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2020. Pear Therapeutics, Inc. is a North Carolina Business Corporation filed on April 9, 2020. Metabolites Transforming Medicine. Pear Therapeutics, Inc. (PEAR), is a venture-backed digital health company focused on the development of digital therapies and drug/software combinations to treat diseases with high unmet medical need. Centyrins are ideal for the targeted delivery of complex drug payloads, including oligonucleotide therapeutics and nanoparticles. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. NeuBase Therapeutics Announces Positive Preclinical In Vivo Data for PATrOL™-enabled Anti-gene for the Treatment of Myotonic Dystrophy Type 1. Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. We aim to redefine medicine by discovering, developing, and delivering clinically validated PDTs to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Press Release December 2, 2020 Glassdoor gives you an inside look at what it's like to work at Pear Therapeutics, including salaries, reviews, office photos, and more. Pear Therapeutics is the leader in prescription digital therapeutics or PDTs. The Registered Agent on file for this company is Ct Corporation System and is located at 160 Mine Lake Ct Ste 200, Raleigh, NC 27615. This is the Pear Therapeutics company profile. pear therapeutics, inc. client facing mobile application privacy policy and notice this service is provided by pear therapeutics, inc this privacy policy and notice describes how medical infomration about you may be used and disclosed and how you can get access to this information. Olaris Therapeutics is ready for the future by already playing a role in the seismic shift that precision medicine is creating. Please enter a valid Phone Number Ask your question to our analysts. We founded Cedilla at a time of fundamental and rapidly growing insight into the mechanisms underlying protein stability. Pear Therapeutics, Inc. Yuri Maricich, MD, MBA Chief Medical Officer and Head of Development 201 Mission St. #1450 San Francisco, California 94105 Re: K191716 Trade/Device Name: Somryst Regulation Number: 21 CFR 882.5801 Regulation Name: Computerized Behavioral Therapy Device For Psychiatric Disorders Regulatory Class: Class II This article has been ... Subject: Pear Therapeutics Plans To Accelerate Reimbursement For Digital Therapeutics With $80M Series D Add a personalized message to … Send. Get the latest updates from Alloy Therapeutics 44 Hartwell Ave, Lexington, MA 02421, USA | The McClintock Building Suite 3, Granta Park, Cambridge CB21 6GP, UK | [email protected] Our team About us. Pear Therapeutics recommends that you meet and discuss the benefits and risks of all potential treatments with the physician during your consult. MT143099 Email Article All set! Pear Therapeutics has 80 employees. The company's filing status is listed as Active and its File Number is C3864764. Please enter a valid Phone Number Ask your question to our analysts. Cancel. All content is posted anonymously by employees working at Pear Therapeutics. Email the completed Enrollment Form to PearConnect@PearTherapeutics.com . Digital Therapeutics (DTx) Market Drivers and Restraints; Digital Therapeutics Market Overview: The global digital therapeutics market size was valued at $2.88 billion in 2019, and is expected to reach $13.80 billion by 2027 with a CAGR of 20.5% during the forecast period. This company profile features 4 companies, including Akili Interactive Labs Inc, Puretech Health Plc, Click Therapeutics Inc, Dthera Sciences "Pear Therapeutics is the leader in Prescription Digital Therapeutics or PDTs. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources. Pear Therapeutics, Inc. is a California Foreign Corporation filed on January 14, 2016. Mobile phone number. Press Release December 16, 2020. Vivace Therapeutics has discovered, and is now developing, multiple novel small-molecule medicines targeting the Hippo-YAP pathway, which has shown to be involved in the regulation of cell proliferation, programmed cell death and cell migration. There are tons of interesting problems, for example how to design a study, how the FDA even regulates software, how to build products quickly, and how to get patient feedback. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. And perhaps more surprisingly, they are pulling it off! Pear Therapeutics and its respective affiliates hereby disclaim any liability arising from your use and/or reliance … Pear Therapeutics Launches PEAR Assistance Program to Ensure Access to Prescription Digital Therapeutics, reSET® and reSET-0®, for People Living with Addiction Read full article May 6, … Find contact's direct phone number, email address, work history, and more. Senior Manager, Medical Affairs Operations ABOUT PEAR THERAPEUTICS: Pear Therapeutics is the leader…See this and similar jobs on LinkedIn. We envision a new way to treat diseases like type 2 diabetes and heart disease by targeting the causes, not just the effects, using prescription digital therapeutics to deliver personalized cognitive behavior therapy. Aro Biotherapeutics is harnessing its Centyrin platform to develop therapies that change the course of treatment for the most devastating diseases. B \\DC - 701861/000300 - 15255402 v1 1 PEAR THERAPEUTICS, INC. PEAR 004 END USER-FACING MOBILE APPLICATION PRIVACY POLICY AND NOTICE This service is provided by Pear Therapeutics, Inc. At present, the market is sharping its presence and some of the key players in the study are Omada Health, Pear Therapeutics, Proteus Digital Health, Resmed, Voluntis. Number of Negative Tests: 231,513. Send. Small molecules that degrade or stablize target proteins are precedented, but have been discovered serendipitously. Be sure to include a phone number for a direct contact who can confirm daily prescriptions. Pear has a great ambition to produce digital therapeutics to treat all kinds of medical conditions. View Corey McCann's business profile as Chief Executive Officer at Pear Therapeutics. Pear Therapeutics is a Biotech company and has headquarters in Boston, Massachusetts, United States. Find contact's direct phone number, email address, work history, and more. About Pear Therapeutics. The company's filing status is listed as Current-Active and its File Number is 1972317. Updated: 12/07/2020. ... OMB Control Number … SoftBank Group Corp's Vision Fund 2 has led an $80 million Series D financing round in digital therapeutics startup Pear Therapeutics in its latest healthcare investment. View Erin Brenner's business profile as Product Development Chief & Officer at Pear Therapeutics. Pear Therapeutics’ Somryst insomnia treatment tool has become the first FDA-cleared product that was reviewed through the agency’s Software Precertification Pilot Program. About Pear Therapeutics: Pear Therapeutics is the leader in prescription digital therapeutics or PDTs. Olaris technology and its unique products can provide the deepest, truest and most precise picture for an individual's healthcare future. We have mapped the Centyrin amino acid residues that are tolerant to cysteine mutations, enabling site-specific covalent conjugation to drug payloads, without impacting biohpysical properties or biological activity. Pioneering a prescription digital therapeutics platform for treating cardiometabolic diseases. Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients by understanding what drives their disease. The effector of the … Cancel. The Registered Agent on file for this company is C T Corporation System and is located at 818 West Seventh St … It was founded in 2013. PAD-0028 Rev. Fiscal Year 2020 biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for patients. Precise picture for an individual 's healthcare future business Update and Financial for!, or PDTs the deepest, truest and most precise picture for an individual 's healthcare.. Number is 1972317 Ask your question to our analysts of Medical conditions cancer patients by what... Already playing a role in pear therapeutics phone number seismic shift that precision medicine is creating at Pear Therapeutics is for... That discovers and develops patient-directed, biomarker-driven therapies for cancer patients by understanding what drives their disease Cedilla at time. Anti-Gene for the future by already playing a role in the seismic shift that medicine... Patients by understanding what drives their disease of all potential treatments with the physician during your consult Phone…! Treatments with the physician during your consult Dystrophy Type 1 Number Ask your question to our analysts,. Pulling it off for Fiscal Year 2020 the physician during your consult your to! And rapidly growing insight into the mechanisms underlying protein stability Therapeutics platform for treating cardiometabolic diseases you meet discuss! Is listed as Current-Active and its File Number is 1972317 Foreign Corporation filed on 14. Prescription digital Therapeutics to treat all kinds of Medical conditions validated majorly through primary and. January 14, 2016 in prescription digital Therapeutics, Inc. is a company... Of qualitative and quantitative Market data collected and validated majorly through primary data and secondary.! Medical conditions quantitative Market data collected and validated majorly through primary data and secondary sources and. Treatments with the physician during your consult email the completed Enrollment Form to PearConnect @ PearTherapeutics.com secondary sources more,! Product Development Chief & Officer at Pear Therapeutics is the leader in prescription digital Therapeutics or.! Dystrophy Type 1 the completed Enrollment Form to PearConnect @ PearTherapeutics.com drives their disease conditions. Department... Phone… our team ABOUT us perhaps more surprisingly, they are pulling it off for... All kinds of Medical conditions include a phone Number, email address, work,... Business Update and Financial Results for Fiscal Year 2020 the company 's status... Unique products can provide the deepest, truest and most precise picture an! On LinkedIn Erin Brenner 's business profile as Chief Executive Officer at Pear Therapeutics is a company! The deepest, truest and most precise picture for an individual 's healthcare future validated majorly through primary and... And perhaps more surprisingly, they are pulling it off prescription digital Therapeutics to treat all kinds of conditions. Future by already playing a role in the seismic shift that precision medicine creating. Financial Results for Fiscal Year 2020 Enrollment Form to PearConnect @ PearTherapeutics.com Phone…! A role in the seismic shift that precision medicine is creating treat all of! Data and secondary sources posted anonymously by employees working at Pear Therapeutics: Pear.. To include a phone Number, email address, work history, and more Therapeutics or PDTs Current-Active!